Although originally believed to be MHC-independent, TCEs may exhibit enhanced T cell expansion via peptide-MHC class I interactions, as seen in CD3 × BCMA bsAbs for multiple myeloma (122). Here, TNFRSF17 is linked to plasma cell myeloma.